Gerald used a lot of words that had to do with increasing shareholder value, but he didn't say any of the words having to do with LymPro revenue guidance for 2015...the only thing that will increase shareholder value in the near term.
The market is echoing it's concern about this after the end of the CC. I wonder if Gerald can hear the echo?
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links